abstract |
The present invention provides novel and improved biogenic amine GPCR modulators; processes for the preparation thereof ; methods for characterizing them; kits for preparing and/or screening them; and methods for diagnosis or treatment utilizing them. Compounds modulating biogenic amine receptors, e.g. norepinephrine are covalently attached to compounds like ascorbate, morphine or EDTA. |